Rhabdoid Tumor: Causes, Symptoms, Diagnosis, Treatment & Prognosis

~Introduction

Rhabdoid tumor is a rare but highly aggressive form of cancer that primarily affects infants and very young children. First identified in the kidney, this tumor is now known to occur in multiple parts of the body, including the brain and soft tissues. Due to its rapid growth and early spread, rhabdoid tumor requires immediate medical attention and specialized treatment.

This detailed article explains everything you need to know about rhabdoid tumor — including its types, causes, symptoms, diagnosis, treatment options, survival rates, and ongoing research developments.

~What is a Rhabdoid Tumor?

A rhabdoid tumor is a fast-growing cancer made up of abnormal cells that appear “rhabdoid” (resembling muscle cells) under a microscope. Despite the name, these tumors do not arise from muscle tissue. Instead, they are linked to genetic mutations affecting tumor suppressor genes.

Rhabdoid tumors most commonly affect:

• The kidneys

• The brain

• Soft tissues throughout the body

These cancers are most frequently diagnosed in children under the age of 3, although rare cases can occur in older children and adults.

~Types of Rhabdoid Tumors

1. Malignant Rhabdoid Tumor of the Kidney (MRTK)

Malignant Rhabdoid Tumor of the Kidney (MRTK) was initially thought to be a variant of Wilms tumor but is now recognized as a distinct and more aggressive cancer. It primarily affects infants and toddlers.

It often presents as a large abdominal mass and may spread rapidly to the lungs or brain.

2. Atypical Teratoid/Rhabdoid Tumor (AT/RT)

Atypical Teratoid/Rhabdoid Tumor (AT/RT) is a rhabdoid tumor that occurs in the central nervous system, most commonly in the cerebellum or brainstem. It is one of the most aggressive pediatric brain tumors.

Symptoms depend on tumor location and may include headaches, vomiting, or developmental delays.

3. Extrarenal Rhabdoid Tumor

These tumors develop outside the kidney and brain, often in soft tissues such as:

• Neck

• Liver

• Chest

• Pelvis

They are rare but equally aggressive.

~Causes and Genetic Factors

Rhabdoid tumors are strongly associated with mutations in the SMARCB1 gene, also known as the INI1 gene. This gene normally helps suppress tumor growth. When it is missing or mutated, uncontrolled cell division occurs.

Some children inherit this mutation, leading to a condition called Rhabdoid Tumor Predisposition Syndrome (RTPS). However, most cases occur sporadically without family history.

Key genetic aspects:

• Loss of SMARCB1 gene function

• Rarely, mutation in SMARCA4 gene

• May be inherited or spontaneous

Genetic counseling is recommended for affected families.

~Risk Factors

Although rhabdoid tumors are rare, certain factors increase risk:

• Age under 3 years

• Genetic mutation in SMARCB1

• Family history of rhabdoid tumor

• Rhabdoid Tumor Predisposition Syndrome

There are no known environmental or lifestyle causes.

~Symptoms of Rhabdoid Tumor

Symptoms vary depending on tumor location.

Kidney Tumor Symptoms:

• Abdominal swelling or mass

• Blood in urine

• Fever

• Irritability

• Weight loss

Brain Tumor (AT/RT) Symptoms:

• Persistent headache

• Vomiting

• Balance problems

• Seizures

• Enlarged head size in infants

Soft Tissue Tumor Symptoms:

• Swelling or lump

• Pain

• Breathing difficulty (if chest involved)

Because these tumors grow rapidly, symptoms often worsen quickly.

~Diagnosis of Rhabdoid Tumor

Early diagnosis is critical due to the tumor’s aggressive nature.

1. Physical Examination

Doctors check for lumps, neurological changes, or abdominal enlargement.

2. Imaging Tests

• Ultrasound

• CT scan

• MRI

MRI is especially important for brain tumors.

3. Biopsy

A tissue sample confirms the diagnosis. Pathologists look for:

• Rhabdoid cell appearance

• Loss of INI1 protein (key diagnostic marker)

4. Genetic Testing

Testing for SMARCB1 mutation helps confirm diagnosis and guide family counseling.

~Staging and Spread

Rhabdoid tumors are often advanced at diagnosis. They can spread (metastasize) to:

• Lungs

• Brain

• Liver

• Lymph nodes

Staging depends on:

• Tumor size

• Spread to distant organs

• Lymph node involvement

Because of early metastasis, aggressive treatment is required.

~Treatment Options

Treatment is intensive and usually combines multiple therapies.

1. Surgery

Complete surgical removal of the tumor is the primary goal when possible.

• Kidney removal (nephrectomy) for MRTK

• Brain tumor resection for AT/RT

However, complete removal is not always achievable.

2. Chemotherapy

High-dose chemotherapy is standard treatment.

Common drugs include:

• Vincristine

• Cyclophosphamide

• Doxorubicin

• Cisplatin

• Etoposide

Chemotherapy may be given before or after surgery.

3. Radiation Therapy

Used particularly in brain tumors, especially in older children. Radiation may be limited in infants due to long-term side effects.

4. Stem Cell Transplant

In some cases, high-dose chemotherapy followed by stem cell rescue is used to improve survival chances.

5. Targeted Therapy and Clinical Trials

Researchers are studying new treatments targeting genetic mutations. Immunotherapy and molecular-targeted drugs are under investigation.

Participation in clinical trials is often recommended.

~Prognosis and Survival Rate

Rhabdoid tumors are among the most aggressive childhood cancers.

Overall survival rates remain low, especially in:

• Infants under 1 year

• Metastatic disease

• Incomplete tumor removal

However, survival has improved with aggressive multimodal therapy.

Early-stage diagnosis and complete surgical removal significantly improve outcomes.

~Complications

Possible complications include:

• Tumor recurrence

• Treatment-related side effects

• Organ damage

• Developmental delays (brain tumor cases)

Long-term follow-up is essential.

~Follow-Up and Survivorship

Children who survive require ongoing monitoring for:

• Recurrence

• Growth and development issues

• Secondary cancers

• Cognitive function (in brain tumor survivors)

Rehabilitation, educational support, and psychological counseling may be needed.

~Advances in Research

Recent research focuses on:

• Targeting SMARCB1 mutation pathways

• Epigenetic therapies

• Precision medicine approaches

• Improved chemotherapy protocols

Genomic studies are helping develop more personalized treatments.

~Emotional and Family Support

A diagnosis of rhabdoid tumor is devastating for families. Support resources include:

• Pediatric oncology teams

• Genetic counselors

• Support groups

• Palliative care specialists

Emotional and psychological care is crucial alongside medical treatment.

~Prevention and Screening

There is no known way to prevent rhabdoid tumors.

However, children with known SMARCB1 mutations may undergo:

• Regular MRI scans

• Routine physical exams

Early detection may improve survival.

~Frequently Asked Questions (FAQs)

1. Is rhabdoid tumor hereditary?
Most cases are not inherited, but some are linked to genetic mutations passed down in families.

2. What age is most affected?
Children under 3 years are most commonly diagnosed.

3. Is rhabdoid tumor curable?
It can be treated, but it is aggressive and survival depends on early diagnosis and response to therapy.

4. How rare is rhabdoid tumor?
It is extremely rare, accounting for a small percentage of pediatric cancers.

5. Can adults get rhabdoid tumors?
Rarely, but most cases occur in infants and toddlers.

~Conclusion

Rhabdoid tumor is a rare and highly aggressive childhood cancer that requires urgent, specialized treatment. Whether occurring in the kidney, brain, or soft tissues, it is linked to genetic mutations and tends to spread quickly.

Although prognosis remains challenging, advances in surgery, chemotherapy, stem cell therapy, and genetic research are improving outcomes. Early detection, comprehensive treatment, and strong family support play vital roles in managing this condition.